Recently, there has been a lot of talk about probiotic food products, but what are probiotics? How do they affect our bodies? Read our article to find the answers to these and other questions on the subject.
Several issues of the new legislation regulating clinical trials and studies started by investigators have been explored from a practical approach during the ‘Conference on Clinical Trials’ organized by the European University and BioClever.
On Wednesday 17th of February 2016, in an effort to provide students with high-quality, relevant, humanistic education, Francisco de Vitoria University of Madrid organized a conference on the importance, role and impact of vaccines not only in developed countries, like ours, but also in developing countries.
To conduct aclinical trial, electronic data collection is currently becoming more common, because new technologies enable us to gather information in a faster and more streamlined way, with the quality assurance required by the end purpose of collecting such data.
In the Spanish pharmaceutical and medical service sector, it has become increasingly popular to work with companies specialized inclinical trialsthat offer their services as CROs(Contract Research Organizations).
At the 11th Congress held by the Medical Association of the Pharmaceutical Industry (AMIFE, as per the Spanish acronym), held on November 12-14 in Madrid, one of the issues discussed was the status of the Clinical Trial Royal Decree, which is currently awaiting the ruling of the State Council, since the text is almost finished, as stated by Mr. César Hernández, Head of the Committee on Medicinal Products for Human Use of the Spanish Agency of Medicinal Products and Medical Devices (AEMPS).
Clinical trials are complex, because pharmaceutical and biotechnological companies follow the strictest testing for what is the fruit of their time, resources, talents and creativity, always in compliance with applicable national and international policies and regulations.